GSK secures FDA breakthrough therapy designation for GSK5764227 in lung cancer treatment

GSK plc (LSE/NYSE: GSK) has announced a significant milestone in its oncology program, with the US Food and Drug Administration (FDA) granting Breakthrough Therapy Designation ... Read More